Our first edition of 2022 focuses on Healthcare and Life Sciences. It is a sector that will once again have the spotlight on it this year as we continue to tackle COVID-19 and its subsequent variants. While the pandemic continues to challenge the sector, governments across the region forge ahead with their plans to expand and upgrade healthcare systems and develop robust world-class healthcare infrastructure.
For the region, healthcare is a vital pillar in diversifying its economies, both locally and as medical tourism hubs. To underpin this, healthcare authorities across the region continue to implement frameworks and regulations that provide structure and accountability.
In this edition, you have unique access to great insights and expert commentary on a number of pertinent healthcare regulatory developments. You will find a topical mix of articles; for example, our lawyers discuss vaccines and returning to work during the pandemic. They take you through several other areas, including stem cell research in Bahrain, clinical research laws in Egypt, and Saudi medical device and pharmaceutical laws.Take a read of the edition
Kais Zayadin joined the Corporate Commercial team in Jordan of Al Tamimi & Company in 2014.
His experience regarding corporate commercial matters has assisted in drafting complex joint venture and shareholder agreements and has advised clients on the most beneficial legal structure for the joint venture.
In addition, he has advised clients on tax matters under Jordanian law including income tax, sales tax, double taxation treaties and other tax issues arising due to various agreements (EPC Contracts and BOT Contracts).
Kais has demonstrated expert knowledge in capital markets and has advised various banks and financial institutions with respect to products, IPO’s and marketing derivatives.
2005 – Legal Practice Course Diploma, College of Law
2005 – LLB Degree, University of Surrey
2009 – Jordanian Bar Association